Physician profile
Alan S Hilibrand
NPI 1609820315
$1,352,407.23
in general payments reported to CMS, 2019-2025
7 companies · $93K in 2025
The $93K reported for 2025 was more than what 92% of Orthopaedic Surgery of The Spine providers received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $426K · 2020: $305K · 2021: $7,617 · 2022: $279K · 2023: $151K · 2024: $92K · 2025: $93K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $335K · Food and Beverage: $383.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $335,307.88 |
| Food and Beverage | $382.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $768,581.00 | 2019-2022 | |
| Zimvie INC. | $353,406.00 | 2022-2023 | |
| Highridge Medical LLC | $183,920.00 | 2024-2025 | Maxan Anterior Cervical Plate System, Altius M-Ini Oct |
| Ctl Medical Corporation | $45,273.72 | 2019-2024 | Spinal |
| Orthofix Medical, INC. | $884.90 | 2021-2023 | |
| Kuros Biosciences USA, INC | $284.67 | 2024-2025 | Magnetos |
| Centinel Spine, LLC | $56.94 | 2023 | Prodisc C |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Hilibrand listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.